Q-Pharm Pty Limited is a specialised contract research organisation / clinical trial unit which undertakes a broad range of early phase (Phase 1 & Phase 2) clinical trials for clients in the global pharmaceutical and
biotechnology industries.
Our clients tell us that the benefits of conducting clinical trials at Q-Pharm are:
SAVE TIME
- Fast clinical trial start-up (~4-6 weeks from ethics submission to commencement of the clinical trial)
- Frequent dates for ethics submission (40 meetings per year total - local & commercial committee options)
SAVE COSTS
- Time is money - our clinical trials are completed on time and within budget
COMFORT IN WORKING WITH AN ESTABLISHED PROVIDER
- Excellent working relationship with local HREC (submitted, managed and conducted > 300 studies) and commercial HREC (multiple submissions approved in single round of review)
- USA (FDA), Europe (AFSSAPS and AEMPS), and South America (ANVISA) inspected
- Data accepted worldwide by regulators
- Safe location (high level of IP protection, low-risk stable destination)
Specialties
Early Phase and Vaccine Clinical Trials, Healthy Volunteer Clinical Trials, First in Human Clinical Trials, Early Phase Patient Trials
Q-Pharm Activity on LinkedIn
-
Q-Pharm Interesting read in THE LANCET demonstrating how important it is to conduct clinical trials in an environment where there are controls for careful monitoring, training, and regulation (and that these controls only work well if they can keep up with the expansion/size of the local industry).
-
Q-Pharm Very interesting outline on the major IT trends for life sciences in 2012 - two of which relate directly to clinical trials!
-
Q-Pharm Take a look at this case study from Dr. Tom Hughes, President and CEO of Zafgen, on how to build innovation from a micro-pharmaceutical approach (including using Australia to fast track clinical development)
